Search Results Search Sort by RelevanceMost Recent Viewpoint Dec 2019 Genome Editing, Ethics, and Politics Isabel Gabel, PhD and Jonathan Moreno, PhD Genome editing raises old questions, but CRISPR arose in a political landscape that vastly differs from the early aughts. AMA J Ethics. 2019;21(12):E1105-1110. doi: 10.1001/amajethics.2019.1105. In the Literature Feb 2001 Sources of Embryonic Stem Cells for Research Faith Lagay, PhD Virtual Mentor. 2001;3(2):35-36. doi: 10.1001/virtualmentor.2001.3.2.jdsc1-0102. Policy Forum Oct 2004 Should Surgery Have an FDA? Robert S. Rhodes, MD Virtual Mentor. 2004;6(10):459-461. doi: 10.1001/virtualmentor.2004.6.10.pfor2-0410. Viewpoint Jun 2012 What Can Physicians Learn from the Neurodiversity Movement? Christina Nicolaidis, MD, MPH The neurodiversity movement challenges us to rethink autism through the lens of human diversity, valuing diversity in neurobiologic development as we would value it in gender, race, ethnicity, religion, or sexual orientation. Virtual Mentor. 2012;14(6):503-510. doi: 10.1001/virtualmentor.2012.14.6.oped1-1206. In the Literature Jun 2019 Disentangling Evidence and Preference in Patient-Clinician Concordance Discussions Leah Z. G. Rand, DPhil and Zackary Berger, MD, PhD How should evidence be used to interpret and inform whether to accommodate patients’ requests for clinicians with specific traits? AMA J Ethics. 2019;21(6):E505-512. doi: 10.1001/amajethics.2019.505.